These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 8548894

  • 1. Myocardial rubidium-82 tissue kinetics assessed by dynamic positron emission tomography as a marker of myocardial cell membrane integrity and viability.
    vom Dahl J, Muzik O, Wolfe ER, Allman C, Hutchins G, Schwaiger M.
    Circulation; 1996 Jan 15; 93(2):238-45. PubMed ID: 8548894
    [Abstract] [Full Text] [Related]

  • 2. Can nitrogen-13 ammonia kinetic modeling define myocardial viability independent of fluorine-18 fluorodeoxyglucose?
    Beanlands RS, deKemp R, Scheffel A, Nahmias C, Garnett ES, Coates G, Johansen HL, Fallen E.
    J Am Coll Cardiol; 1997 Mar 01; 29(3):537-43. PubMed ID: 9060890
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18F-fluorodeoxyglucose.
    Bonow RO, Dilsizian V, Cuocolo A, Bacharach SL.
    Circulation; 1991 Jan 01; 83(1):26-37. PubMed ID: 1984883
    [Abstract] [Full Text] [Related]

  • 6. The utility of 82Rb PET for myocardial viability assessment: Comparison with perfusion-metabolism 82Rb-18F-FDG PET.
    Moody JB, Hiller KM, Lee BC, Poitrasson-Rivière A, Corbett JR, Weinberg RL, Murthy VL, Ficaro EP.
    J Nucl Cardiol; 2019 Apr 01; 26(2):374-386. PubMed ID: 30809755
    [Abstract] [Full Text] [Related]

  • 7. Washout of ⁸²Rb as a marker of impaired tissue integrity, obtained by list-mode cardiac PET/CT: relationship with perfusion/metabolism patterns of myocardial viability.
    Chien DT, Bravo P, Higuchi T, Merrill J, Bengel FM.
    Eur J Nucl Med Mol Imaging; 2011 Aug 01; 38(8):1507-15. PubMed ID: 21528386
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Hibernating myocardium versus scar: severity of irreversible decreased myocardial perfusion in prediction of tissue viability.
    Go RT, MacIntyre WJ, Saha GB, Cook SA, Neumann DR, Chen EQ, Underwood DA, Kaczur T.
    Radiology; 1995 Jan 01; 194(1):151-5. PubMed ID: 7997543
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Identification and differentiation of resting myocardial ischemia and infarction in man with positron computed tomography, 18F-labeled fluorodeoxyglucose and N-13 ammonia.
    Marshall RC, Tillisch JH, Phelps ME, Huang SC, Carson R, Henze E, Schelbert HR.
    Circulation; 1983 Apr 01; 67(4):766-78. PubMed ID: 6600659
    [Abstract] [Full Text] [Related]

  • 17. Myocardial viability assessment by PET: (82)Rb defect washout does not predict the results of metabolic-perfusion mismatch.
    Stankewicz MA, Mansour CS, Eisner RL, Churchwell KB, Williams BR, Sigman SR, Streeter J, Patterson RE.
    J Nucl Med; 2005 Oct 01; 46(10):1602-9. PubMed ID: 16204709
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.